Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

James Falko to Adult

This is a "connection" page, showing publications James Falko has written about Adult.

 
Connection Strength
 
 
 
0.105
 
  1. Sundaram V, Hanna AN, Koneru L, Newman HA, Falko JM. Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metab. 1997 Oct; 82(10):3421-4.
    View in: PubMed
    Score: 0.008
  2. Glueck CJ, Streicher P, Wang P, Sprecher D, Falko JM. Treatment of severe familial hypertriglyceridemia during pregnancy with very-low-fat diet and n-3 fatty acids. Nutrition. 1996 Mar; 12(3):202-5.
    View in: PubMed
    Score: 0.007
  3. Cottrell DA, Bello FA, Falko JM. 17 alpha-hydroxylase deficiency masquerading as primary hyperaldosteronism. Am J Med Sci. 1990 Dec; 300(6):380-2.
    View in: PubMed
    Score: 0.005
  4. Chevinsky AH, Minton JP, Falko JM. Metastatic pheochromocytoma associated with multiple endocrine neoplasia syndrome type II. Arch Surg. 1990 Jul; 125(7):935-8.
    View in: PubMed
    Score: 0.005
  5. La Londe MA, Graffagnino CL, Falko JM, Snow RJ, Spencer K, Caulin-Glaser T. Effect of a weight management program on the determinants and prevalence of metabolic syndrome. Obesity (Silver Spring). 2008 Mar; 16(3):637-42.
    View in: PubMed
    Score: 0.004
  6. Trapnell BC, Mavko LE, Birskovich LM, Falko JM. Metoclopramide suppositories in the treatment of diabetic gastroparesis. Arch Intern Med. 1986 Nov; 146(11):2278-9.
    View in: PubMed
    Score: 0.004
  7. Osei K, Holland G, Falko JM. Indapamide. Effects on apoprotein, lipoprotein, and glucoregulation in ambulatory diabetic patients. Arch Intern Med. 1986 Oct; 146(10):1973-7.
    View in: PubMed
    Score: 0.004
  8. Osei K, Falko JM. Clinical features, diagnosis and management of insulinoma in 16 consecutive patients: cost-ineffectiveness of non-invasive imaging modalities. Ohio State Med J. 1984 Dec; 80(12):864-9.
    View in: PubMed
    Score: 0.003
  9. Osei K, Kramer DS, Malarkey WB, Falko JM. Pregnancy complicated by insulinoma. Am J Med Sci. 1984 Oct; 288(3):133-5.
    View in: PubMed
    Score: 0.003
  10. Bossetti BM, Kocher LM, Moranz JF, Falko JM. The effects of physiologic amounts of simple sugars on lipoprotein, glucose, and insulin levels in normal subjects. Diabetes Care. 1984 Jul-Aug; 7(4):309-12.
    View in: PubMed
    Score: 0.003
  11. Falko JM, Maeder MC, Conway C, Mazzaferri EL, Skillman TG. Primary hyperparathyroidism: analysis of 220 patients with special emphasis on familial hypocalciuric hypercalcemia. Heart Lung. 1984 Mar; 13(2):124-31.
    View in: PubMed
    Score: 0.003
  12. Falko JM, Reynolds JC, O'Dorisio TM, Bossetti B, Cataland S. The role of gastric inhibitory polypeptide in the augmented insulin response to sucrose. Diabetes Care. 1982 Jul-Aug; 5(4):379-85.
    View in: PubMed
    Score: 0.003
  13. Hawley PC, Falko JM. "Pseudo" renal failure after isopropyl alcohol intoxication. South Med J. 1982 May; 75(5):630-1.
    View in: PubMed
    Score: 0.003
  14. Falko JM, O'Dorisio TM, Cataland S. Improvement of high-density lipoprotein-cholesterol levels. Ambulatory type I diabetics treated with the subcutaneous insulin pump. JAMA. 1982 Jan 01; 247(1):37-9.
    View in: PubMed
    Score: 0.003
  15. Zull DN, Falko JM. Metrizamide cisternography in the investigation of the empty sella syndrome. Arch Intern Med. 1981 Mar; 141(4):487-9.
    View in: PubMed
    Score: 0.003
  16. Falko JM, Crockett SE, Cataland S, O'Dorisio TM, Kramer W, Mazzaferri EL. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man. Clin Endocrinol (Oxf). 1980 Dec; 13(6):587-93.
    View in: PubMed
    Score: 0.003
  17. Falko JM, Schonfeld G, Witztum JL, Kolar JB, Salmon P. Effects of short-term high carbohydrate, fat-free diet on plasma levels of Apo C-II and Apo C-III and on the Apo C subspecies in human plasma lipoproteins. Metabolism. 1980 Jul; 29(7):654-61.
    View in: PubMed
    Score: 0.003
  18. Falko JM, Schonfeld G, Witztum JL, Kolar JB, Weidman SW, Steelman R. Effects of diet on apoprotein E levels and on the apoprotein E subspecies in human plasma lipoproteins. J Clin Endocrinol Metab. 1980 Mar; 50(3):521-8.
    View in: PubMed
    Score: 0.002
  19. Falko JM, Witztum JL, Schonfeld G, Bateman J. Dietary treatment of type V hyperlipoproteinemia fails to normalize low levels of high-density lipoprotein cholesterol. Ann Intern Med. 1979 Nov; 91(5):750-1.
    View in: PubMed
    Score: 0.002
  20. Falko JM, Witztum JL, Schonfeld G, Weidman SW, Kolar JB. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy. Am J Med. 1979 Feb; 66(2):303-10.
    View in: PubMed
    Score: 0.002
  21. Sundaram V, Hanna AN, Lubow GP, Koneru L, Falko JM, Sharma HM. Inhibition of low-density lipoprotein oxidation by oral herbal mixtures Maharishi Amrit Kalash-4 and Maharishi Amrit Kalash-5 in hyperlipidemic patients. Am J Med Sci. 1997 Nov; 314(5):303-10.
    View in: PubMed
    Score: 0.002
  22. Thomas FB, Sinar D, Caldwell JH, Mekhjian HS, Falko JM. Stimulation of pancreatic secretion of water and electrolytes by furosemide. Gastroenterology. 1977 Aug; 73(2):221-5.
    View in: PubMed
    Score: 0.002
  23. Falko JM. Hazards in antihypertension therapy. Ann Intern Med. 1977 Jan; 86(1):111-2.
    View in: PubMed
    Score: 0.002
  24. Falko JM, Guy JT, Smith RE, Mazzaferri EL. Primary hyperparathyroidism and anemia. Arch Intern Med. 1976 Aug; 136(8):887-9.
    View in: PubMed
    Score: 0.002
  25. Falko JM, Cohen JR. Letter: Erythrocytosis and hypothyroidism. Ann Intern Med. 1976 Apr; 84(4):446-7.
    View in: PubMed
    Score: 0.002
  26. Jhiang SM, Fithian L, Weghorst CM, Clark OH, Falko JM, O'Dorisio TM, Mazzaferri EL. RET mutation screening in MEN2 patients and discovery of a novel mutation in a sporadic medullary thyroid carcinoma. Thyroid. 1996 Apr; 6(2):115-21.
    View in: PubMed
    Score: 0.002
  27. Falko JM, Bush CA, Tzagournis M, Thomas FB. Case report. Congestive heart failure complicating the hungry bone syndrome. Am J Med Sci. 1976 Jan-Feb; 271(1):85-9.
    View in: PubMed
    Score: 0.002
  28. Falko JM, Crockett SE, Cataland S, Mazzaferri EL. Gastric inhibitory polypeptide (GIP) stimulated by fat ingestion in man. J Clin Endocrinol Metab. 1975 Aug; 41(2):260-5.
    View in: PubMed
    Score: 0.002
  29. Falko JM, Mekhjian HS, Thomas FB. Silent pancreatic pseudocyst. An unusual cause of extrahepatic biliary obstruction. Am J Dig Dis. 1975 Jun; 20(6):583-87.
    View in: PubMed
    Score: 0.002
  30. Bello F, Falko JM, O'Dorisio TM, Osei K. The use of continuous subcutaneous octreotide infusion in brittle type 1 diabetic patients. Diabet Med. 1991 May; 8(4):385-7.
    View in: PubMed
    Score: 0.001
  31. Osei K, Falko JM, O'Dorisio TM, Fields PG, Bossetti B. Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients. J Clin Endocrinol Metab. 1986 Feb; 62(2):325-30.
    View in: PubMed
    Score: 0.001
  32. Osei K, Falko JM, Fields PG, Bossetti B, O'Dorisio TM. The effects of carbohydrate-enriched meals on glucose turnover and metabolic clearance rates of glucose in type 2 diabetic patients. Diabetologia. 1986 Feb; 29(2):100-5.
    View in: PubMed
    Score: 0.001
  33. Abdel-Nabi H, Hinkle GH, Falko JM, Kelly D, Olsen JO, Martin EW. Iodine-131 labeled anti-CEA antibodies uptake by H?rthle cell carcinoma. Clin Nucl Med. 1985 Oct; 10(10):713-5.
    View in: PubMed
    Score: 0.001
  34. Osei K, Falko JM, O'Dorisio TM, Adam DR. Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperthyroidism. Diabetes Care. 1985 Sep-Oct; 8(5):436-9.
    View in: PubMed
    Score: 0.001
  35. Osei K, Falko JM, O'Dorisio TM, Adam DR. Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperthyroid patients. Diabetes Care. 1984 Sep-Oct; 7(5):471-5.
    View in: PubMed
    Score: 0.001
  36. Osei K, Falko JM, Nelson KP, Stephens R. Diabetogenic effect of pentamidine. In vitro and in vivo studies in a patient with malignant insulinoma. Am J Med. 1984 Jul; 77(1):41-6.
    View in: PubMed
    Score: 0.001
  37. Levin P, Falko JM, O'Dorisio TM, Cataland S. Limitations in usefulness of single dose intermediate acting insulin: a rapid response pattern in some type I diabetics. Am J Med Sci. 1983 Nov-Dec; 286(3):11-7.
    View in: PubMed
    Score: 0.001
  38. Hill SA, Falko JM, Wilson CB, Hunt WE. Thyrotrophin-producing pituitary adenomas. J Neurosurg. 1982 Oct; 57(4):515-9.
    View in: PubMed
    Score: 0.001
  39. Friedman CI, Falko JM, Patel ST, Kim MH, Newman HA, Barrows H. Serum lipoprotein responses during active and stable weight reduction in reproductive obese females. J Clin Endocrinol Metab. 1982 Aug; 55(2):258-62.
    View in: PubMed
    Score: 0.001
  40. Yovos JG, Patel ST, Falko JM, Newman HA, Hill DS. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia. J Clin Endocrinol Metab. 1982 Jun; 54(6):1210-5.
    View in: PubMed
    Score: 0.001
  41. O'Dorisio TM, Falko JM, Cataland S, Almoney RW, George JM, Mazzaferri EL, Reynolds JC. Gastrin Responses to a test meal in patients with familial medullary thyroid carcinoma. J Clin Endocrinol Metab. 1982 Apr; 54(4):798-802.
    View in: PubMed
    Score: 0.001
  42. Schear EA, Falko JM, Cataland S, Johnson J, Fanning W. Diabetes insipidus and breast cancer. South Med J. 1982 Mar; 75(3):354-6.
    View in: PubMed
    Score: 0.001
  43. Abdel-Nabi H, Scheu J, Ragosin R, Falko JM, Olsen J. Thyroid uptake of Tc-99m compromising in vivo RBC tagging. J Nucl Med. 1981 Nov; 22(11):1018-9.
    View in: PubMed
    Score: 0.001
  44. Pariser SF, Reynolds JC, Falko JM, Jones BA, Mencer DL. Arrhythmia induced by a tricyclic antidepressant in a patient with undiagnosed mitral valve prolapse. Am J Psychiatry. 1981 Apr; 138(4):522-3.
    View in: PubMed
    Score: 0.001
  45. Levin PA, Falko JM, Dixon K, Gallup EM, Saunders W. Benign parotid enlargement in bulimia. Ann Intern Med. 1980 Dec; 93(6):827-9.
    View in: PubMed
    Score: 0.001
  46. Crockett SE, Cataland S, Falko JM, Mazzaferri EL. The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects. J Clin Endocrinol Metab. 1976 Jun; 42(6):1098-103.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)